Dr. Tim A. Fischell, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 45
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 62
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
MI license 4301068581
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Bronson Methodist Hospital Kalamazoo, MI
- Bronson Battle Creek Hospital Battle Creek, MI
- Borgess Medical Center Kalamazoo, MI
- Mt. Graham Regional Medical Center Safford, AZ
Medical groups
- Ascension Medical Group Promed (262 clinicians)
- Mt Graham Regional Medical Center Inc (67 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 62
- Services billed
- 138
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 58 | 30 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | 25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 15 | 15 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | 13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Kalamazoo, MI | 77 |
| Amlodipine Besylate Other prescribers in Kalamazoo, MI | 66 |
| Metoprolol Succinate Other prescribers in Kalamazoo, MI | 62 |
| Ranolazine Er (ranolazine) Other prescribers in Kalamazoo, MI | 53 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Kalamazoo, MI | 42 |
| Nitroglycerin Other prescribers in Kalamazoo, MI | 34 |
| Metoprolol Tartrate Other prescribers in Kalamazoo, MI | 32 |
| Repatha Sureclick (evolocumab) Other prescribers in Kalamazoo, MI | 31 |
| Furosemide Other prescribers in Kalamazoo, MI | 31 |
| Lisinopril Other prescribers in Kalamazoo, MI | 26 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 46 payments worth $1,748 in total to this clinician.
| Stryker Corporation | $366 |
|---|---|
| Cordis US Corp. | $203 |
| Abbott Laboratories | $164 |
| Recor Medical Inc | $147 |
| Shockwave Medical, Inc | $112 |
| Edwards Lifesciences Corporation | $106 |
| Boston Scientific Corporation | $99.14 |
| Abiomed | $80.97 |
| Food and Beverage | $1,748 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,990 in research payments for these studies, mostly to the institutions running them.
- A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis
Medalliance LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.